Literature DB >> 23511692

Does acetaminophen activate endogenous pain inhibition in chronic fatigue syndrome/fibromyalgia and rheumatoid arthritis? A double-blind randomized controlled cross-over trial.

Mira Meeus1, Kelly Ickmans, Filip Struyf, Linda Hermans, Kevin Van Noesel, Jorinde Oderkerk, Luc S Declerck, Greta Moorkens, Guy Hans, Sofie Grosemans, Jo Nijs.   

Abstract

BACKGROUND: Although enhanced temporal summation (TS) and conditioned pain modulation (CPM), as characteristic for central sensitization, has been proved to be impaired in different chronic pain populations, the exact nature is still unknown.
OBJECTIVES: We examined differences in TS and CPM in 2 chronic pain populations, patients with both chronic fatigue syndrome (CFS) and comorbid fibromyalgia (FM) and patients with rheumatoid arthritis (RA), and in sedentary, healthy controls, and evaluated whether activation of serotonergic descending pathways by acetaminophen improves central pain processing. STUDY
DESIGN: Double-blind randomized controlled trial with cross-over design.
METHODS: Fifty-three women (19 CFS/FM patients, 16 RA patients, and 18 healthy women) were randomly allocated to the experimental group (1 g acetaminophen) or the placebo group (1 g dextrose). Participants underwent an assessment of endogenous pain inhibition, consisting of an evaluation of temporal summation with and without conditioned pain modulation (CPM). Seven days later groups were crossed-over. Patients and assessors were blinded for the allocation.
RESULTS: After intake of acetaminophen, pain thresholds increased slightly in CFS/FM patients, and decreased in the RA and the control group. Temporal summation was reduced in the 3 groups and CPM at the shoulder was better overall, however only statistically significant for the RA group. Healthy controls showed improved CPM for both finger and shoulder after acetaminophen, although not significant. LIMITATIONS: The influence of acetaminophen on pain processing is inconsistent, especially in the patient groups examined.
CONCLUSION: This is the first study comparing the influence of acetaminophen on central pain processing in healthy controls and patients with CFS/FM and RA. It seems that CFS/FM patients present more central pain processing abnormalities than RA patients, and that acetaminophen may have a limited positive effect on central pain inhibition, but other contributors have to be identified and evaluated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23511692

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  5 in total

1.  Interrelationships between pain processing, cortisol and cognitive performance in chronic whiplash-associated disorders.

Authors:  Mira Meeus; Jessica Van Oosterwijck; Kelly Ickmans; Isabel Baert; Iris Coppieters; Nathalie Roussel; Filip Struyf; Nathalie Pattyn; Jo Nijs
Journal:  Clin Rheumatol       Date:  2013-12-13       Impact factor: 2.980

Review 2.  Mechanisms, impact and management of pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Nat Rev Rheumatol       Date:  2014-05-27       Impact factor: 20.543

Review 3.  Mechanisms for Joint Pain in Rheumatoid Arthritis (RA): from Cytokines to Central Sensitization.

Authors:  Angela Zhang; Yvonne C Lee
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

Review 4.  Non-inflammatory Causes of Pain in Patients with Rheumatoid Arthritis.

Authors:  Sean D Boyden; Imtiyaz N Hossain; Alyssa Wohlfahrt; Yvonne C Lee
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

5.  Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light.

Authors:  Rajesh Khanna; Amol Patwardhan; Xiaofang Yang; Wennan Li; Song Cai; Yingshi Ji; Lindsey A Chew; Angie Dorame; Shreya S Bellampalli; Ryan W Schmoll; Janalee Gordon; Aubin Moutal; Todd W Vanderah; Frank Porreca; Mohab M Ibrahim
Journal:  J Pain       Date:  2019-05-02       Impact factor: 5.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.